A phase-3b open-label study to further individualize efgartigimod treatment options for patients with generalized myasthenia gravisKelly Gwathmey, Gregory Sahagian,Yessar Hussain, Marc Feinberg,Ali Habib,Thomas Skripuletz,Tobias Ruck, Edward Brauer,Deborah Gelinas, Sihui Zhao, Anna Bogatyreva,Renato MantegazzaMUSCLE & NERVE(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要